Sequent Scientific Limited Stock Fundamentals
| SEQUENT Stock | 199.27 1.09 0.55% |
Sequent Scientific Limited fundamentals help investors to digest information that contributes to Sequent Scientific's financial success or failures. It also enables traders to predict the movement of Sequent Stock. The fundamental analysis module provides a way to measure Sequent Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sequent Scientific stock.
At this time, Sequent Scientific's EBITDA is comparatively stable compared to the past year. Discontinued Operations is likely to gain to about 5.1 B in 2024, whereas Depreciation And Amortization is likely to drop slightly above 375 M in 2024. Sequent | Select Account or Indicator |
Sequent Scientific Limited Company Return On Equity Analysis
Sequent Scientific's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sequent Scientific Return On Equity | -0.0405 |
Most of Sequent Scientific's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sequent Scientific Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Sequent Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Sequent Scientific Limited has a Return On Equity of -0.0405. This is much lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on equity for all India stocks is notably higher than that of the company.
Sequent Scientific Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sequent Scientific's current stock value. Our valuation model uses many indicators to compare Sequent Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sequent Scientific competition to find correlations between indicators driving Sequent Scientific's intrinsic value. More Info.Sequent Scientific Limited is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sequent Scientific's earnings, one of the primary drivers of an investment's value.Sequent Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sequent Scientific's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sequent Scientific could also be used in its relative valuation, which is a method of valuing Sequent Scientific by comparing valuation metrics of similar companies.Sequent Scientific is currently under evaluation in return on equity category among its peers.
Sequent Fundamentals
| Return On Equity | -0.0405 | ||||
| Return On Asset | 0.0031 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 53.69 B | ||||
| Shares Outstanding | 249.35 M | ||||
| Shares Owned By Insiders | 52.98 % | ||||
| Shares Owned By Institutions | 13.16 % | ||||
| Price To Book | 7.29 X | ||||
| Price To Sales | 3.49 X | ||||
| Revenue | 13.7 B | ||||
| Gross Profit | 5.63 B | ||||
| EBITDA | 549.8 M | ||||
| Net Income | (358.69 M) | ||||
| Total Debt | 4.88 B | ||||
| Book Value Per Share | 26.37 X | ||||
| Cash Flow From Operations | 305.95 M | ||||
| Earnings Per Share | 0.66 X | ||||
| Target Price | 133.5 | ||||
| Number Of Employees | 1.2 K | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 48.54 B | ||||
| Total Asset | 15.4 B | ||||
| Retained Earnings | 1.2 B | ||||
| Working Capital | 1.96 B | ||||
| Net Asset | 15.4 B |
About Sequent Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sequent Scientific Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sequent Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sequent Scientific Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 81.3 M | 77.2 M | |
| Total Revenue | 13.7 B | 7.7 B | |
| Cost Of Revenue | 8.1 B | 4.4 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sequent Stock Analysis
When running Sequent Scientific's price analysis, check to measure Sequent Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sequent Scientific is operating at the current time. Most of Sequent Scientific's value examination focuses on studying past and present price action to predict the probability of Sequent Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sequent Scientific's price. Additionally, you may evaluate how the addition of Sequent Scientific to your portfolios can decrease your overall portfolio volatility.